Drugs Made In America Acquisition II Corp.
(NASDAQ) DMIIU
Drugs Made In America Acquisition II Corp. Financials at a Glance
Market Cap
$657.06M
Revenue (TTM)
$0.00
Net Income (TTM)
$0.19
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-0.31 (Low)
Dividend
$0.00
Beta (Volatility)
-0.31 (Low)
Price
$10.02
Volume
22
Open
$10.03
Price
$10.02
Volume
22
Open
$10.03
Previous Close
$10.02
Daily Range
$10.02 - $10.04
52-Week Range
$9.94 - $10.80
Dividend
$0.00
Beta (Volatility)
-0.31 (Low)
Price
$10.02
Volume
22
Open
$10.03
Previous Close
$10.02
Daily Range
$10.02 - $10.04
52-Week Range
$9.94 - $10.80
DMIIU News
DMIIU: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Drugs Made In America Acquisition II Corp.
Industry
Capital Markets
Sector
FinancialsEmployees
2
CEO
Lynn Stockwell
Headquarters
Fort Lauderdale, FL 33301, US
DMIIU Financials
Key Financial Metrics (TTM)
Gross Margin
N/A
Operating Margin
N/A
Net Income Margin
N/A
Return on Equity
0%
Return on Capital
N/A
Return on Assets
N/A
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
N/A
Stock Overview
Market Cap
$657.06M
Shares Outstanding
65.58M
Volume
22
Short Interest
0.00%
Avg. Volume
15.66K
Financials (TTM)
Gross Profit
N/A
Operating Income
N/A
EBITDA
N/A
Operating Cash Flow
N/A
Capital Expenditure
N/A
Free Cash Flow
N/A
Cash & ST Invst.
N/A
Total Debt
N/A
Drugs Made In America Acquisition II Corp. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
N/A
N/A
Market Cap
$657.06M
N/A
Market Cap/Employee
$316.75
N/A
Employees
2
N/A
Net Income
$0.05
N/A
EBITDA
$0.16
N/A
Quarterly Fundamentals
Net Cash
$0.32
N/A
Accounts Receivable
N/A
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
N/A
N/A
Return on Invested Capital
129.99%
N/A
Free Cash Flow
$0.69
N/A
Operating Cash Flow
$0.69
N/A